Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald P Taylor

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Blood|November 21, 2007
NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complementSiao-Yi Wang, Emilian Racila, Ronald P Taylor, et al.
Malaria Journal|January 13, 2009
Complement consumption in children with Plasmodium falciparum malariaNancy K Nyakoe, Ronald P Taylor, Joseph N Makumi, et al.
Molecular Immunology|August 6, 2013
Activation of complement by monoclonal antibodies that target cell-associated β₂-microglobulin: implications for cancer immunotherapyMichael J Pokrass, Monica F Liu, Margaret A Lindorfer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: potential implications for the pathogenesis of anemia in malariaAndrew W Pawluczkowycz, Margaret A Lindorfer, John N Waitumbi, et al.
Molecular Immunology|September 5, 2007
Mechanisms of killing by anti-CD20 monoclonal antibodiesMartin J Glennie, Ruth R French, Mark S Cragg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2010
The direction of plasma membrane exchange between lymphocytes and accessory cells by trogocytosis is influenced by the nature of the accessory cellSandrine Daubeuf, Margaret A Lindorfer, Ronald P Taylor, et al.
Journal of Immunological Methods|October 16, 2002
Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse modelAndrea L Henderson, Margaret A Lindorfer, Adam D Kennedy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Analyses of the in vivo trafficking of stoichiometric doses of an anti-complement receptor 1/2 monoclonal antibody infused intravenously in miceEmily C Whipple, Ryan S Shanahan, Andrew H Ditto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
The shaving reaction: rituximab/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytesPaul V Beum, Adam D Kennedy, Michael E Williams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
Binding of rituximab, trastuzumab, cetuximab, or mAb T101 to cancer cells promotes trogocytosis mediated by THP-1 cells and monocytesPaul V Beum, David A Mack, Andrew W Pawluczkowycz, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Blood|November 21, 2007
NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complementSiao-Yi Wang, Emilian Racila, Ronald P Taylor, et al.
Malaria Journal|January 13, 2009
Complement consumption in children with Plasmodium falciparum malariaNancy K Nyakoe, Ronald P Taylor, Joseph N Makumi, et al.
Molecular Immunology|August 6, 2013
Activation of complement by monoclonal antibodies that target cell-associated β₂-microglobulin: implications for cancer immunotherapyMichael J Pokrass, Monica F Liu, Margaret A Lindorfer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: potential implications for the pathogenesis of anemia in malariaAndrew W Pawluczkowycz, Margaret A Lindorfer, John N Waitumbi, et al.
Molecular Immunology|September 5, 2007
Mechanisms of killing by anti-CD20 monoclonal antibodiesMartin J Glennie, Ruth R French, Mark S Cragg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2010
The direction of plasma membrane exchange between lymphocytes and accessory cells by trogocytosis is influenced by the nature of the accessory cellSandrine Daubeuf, Margaret A Lindorfer, Ronald P Taylor, et al.
Journal of Immunological Methods|October 16, 2002
Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse modelAndrea L Henderson, Margaret A Lindorfer, Adam D Kennedy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Analyses of the in vivo trafficking of stoichiometric doses of an anti-complement receptor 1/2 monoclonal antibody infused intravenously in miceEmily C Whipple, Ryan S Shanahan, Andrew H Ditto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
The shaving reaction: rituximab/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytesPaul V Beum, Adam D Kennedy, Michael E Williams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
Binding of rituximab, trastuzumab, cetuximab, or mAb T101 to cancer cells promotes trogocytosis mediated by THP-1 cells and monocytesPaul V Beum, David A Mack, Andrew W Pawluczkowycz, et al.
Pageof 10